Position Overview :
Genentech is seeking a Franchise Head, Clinical Development Global Head Hematology - NHL / CLLwith clinical and drug development experience to lead the NHL / CLL Hematology Global Franchise within our Hematology / Oncology Late Development organization.
This individual will be responsible for leadership, management, and strategic clinical oversight of the NHL / CLL Hematology Global Franchise.
The position will have significant accountability for setting strategy across these programs. The position will involve clinical development of novel agents targeting a number of diseases in the NHL / CLL Hematology setting.
In addition to managing a large global clinical development team, the Global Head of NHL / CLL Hematology Cancer will be responsible for providing guidance and oversight for the design, implementation, monitoring, analysis, and reporting of studies conducted for all NHL / CLL Hematology Cancer programs.
Context and Key Responsibilities :
This is a global role reporting to the Senior Vice President, Global Head of Clinical Development Oncology, Hematology. Member of the Product Development Hematology / Oncology Leadership Team (PDO LT) and cross-
functional Joint Oncology Leadership Team (JOLT). MD with Board Certification or eligibility in Hematology and clinical practice experience required as well as strong scientific competence demonstrated by peer reviewed publications or production of clinical expert reports.
Partner and Co-Lead the Hematology Franchise with the GPS (Global Product Strategy) lead for all funding decisions and priorities in NHL / CLL, and responsible for overarching strategy in NHL / CLL Hematology cancer.
Closely manage plans with all other therapeutic area franchises. Ensures GDLs and DLs (Global Development Leads and Development Leads) for each molecule manage their respective Development Working Groups with excellence and technical rigor.
Accountability to deliver late stage NHL / CL hematology clinical development plans, enabling regulatory submissions and approvals.
Noted disease area expert with credibility to interface with key external regulatory and healthcare organizations and stakeholders (i.
e. FDA, EMA, other Regulatory bodies, Payer organizations, Advisory Committees, Therapeutic Area Experts, and represent company for media, analysts).
Broadly represents the interests of Oncology and Hematology late development within Roche and Genentech, as a member of the Hematology Leadership Team, as well as through interactions with Research, Early Development, Medical Affairs, Commercial, Regulatory and Business Development senior leaders.
Contributes to the Late Stage Portfolio Committee (LSPC). Leads the strategic clinical oversight of the NHL / CLL Hematology late stage development portfolio with significant accountability for setting global strategy across these programs.
Ensures consistent and effective communication across all sites.
Accountable for building global working capability and establishing clear success metrics. Coach, manage and support employees to achieve business goals.
Actively manage talent and career development. Maintain and develop a positive organizational culture, by promoting the values of the focus on patients, science, and our people.
Prepare and manage resource and capacity, utilizing resources in the most efficient way. Determine and manage expenditures and budget within the NHL / CLL Hematology cancer late stage global franchise.
Key Accountabilities :
Critical Experiences and Qualifications :
Technical / Functional Skill & Knowledge Areas :
Leadership & Other Key Behaviors :
threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
Roche is an equal opportunity employer and strictly prohibits unlawful discrimination based upon an individual’s race, color, religion, gender, sexual orientation, gender identity / expression, national origin / ancestry, age, mental / physical disability, medical condition, marital status, veteran status, or any other characteristic protected by law.